Patients
| Country | Value | Year |
|---|---|---|
| Iraq | 3.4 | 2025 |
| Jordan | 4.8 | 2025 |
| Lebanon | 10.4 | 2025 |
| Palestine | 3.9 | 2025 |
| Qatar | 1.7 | 2025 |
| Saudi Arabia | 3.1 | 2025 |
| Syria | 4.8 | 2025 |
| UAE | 1.8 | 2025 |
| Yemen | 2.5 | 2025 |
Updated
Reviewed by Vidhi Upadhyay
Middle East Orthobiologics Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$231.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $268.2 Mn | — | — |
| 2025 (base) | $286.4 Mn | +$18.2 Mn | — |
| 2026 (forecast) | $305.9 Mn | +$19.5 Mn | +6.8% |
| 2027 (forecast) | $326.7 Mn | +$20.8 Mn | +14.1% |
| 2028 (forecast) | $348.9 Mn | +$22.2 Mn | +21.8% |
| 2029 (forecast) | $372.6 Mn | +$23.7 Mn | +30.1% |
| 2030 (forecast) | $398.0 Mn | +$25.3 Mn | +38.9% |
| 2031 (forecast) | $425.0 Mn | +$27.1 Mn | +48.4% |
| 2032 (forecast) | $453.9 Mn | +$28.9 Mn | +58.5% |
| 2033 (forecast) | $484.8 Mn | +$30.9 Mn | +69.3% |
| 2034 (forecast) | $517.8 Mn | +$33.0 Mn | +80.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $286.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $517.8 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Medtronic, Stryker, Zimmer Biomet Holdings, Inc., Bioventus, Orthofix Medical (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Orthobiologics use natural substances such as bone grafts, growth factors and cells to help bones and soft tissue heal.
Key segments of the orthobiologics market include product (Bone Grafts, Platelet-Rich Plasma and Stem Cells) and application (Spinal Fusion, Trauma and Sports Injuries).
An ageing and more active population, more sports injuries, rising obesity and better implants and procedures are driving the orthobiologics market.
Same-day joint surgery, robotics, smart implants and biologic treatments give the orthobiologics market room to grow.
High procedure costs, pricing pressure from hospitals, recalls and long recovery times hold back the orthobiologics market.
The orthobiologics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)[1] and EDE (UAE)[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[3] and mandatory health insurance (UAE)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Council of Health Insurance. Checked 14 Nov 2026.
[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how orthobiologics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.
What doctors and scientists are doing in Orthobiologics right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| Iraq | 3.4 | 2025 |
| Jordan | 4.8 | 2025 |
| Lebanon | 10.4 | 2025 |
| Palestine | 3.9 | 2025 |
| Qatar | 1.7 | 2025 |
| Saudi Arabia | 3.1 | 2025 |
| Syria | 4.8 | 2025 |
| UAE | 1.8 | 2025 |
| Yemen | 2.5 | 2025 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East
Middle East
Middle East
Digital Health · Middle East
Pharmaceuticals · Middle East
Pharmaceuticals · Middle East
OTC & Nutraceuticals · Middle East
Healthcare Services · Middle East
Pharmaceuticals · Middle East